sections button arrow
Cancer Discovery editor-in-chief Luis A. Diaz, Jr.

Scientific Publishing

tooltip iconLuis A. Diaz, Jr., MD, FAACR, Co-Editor-in-Chief of Cancer Discovery, discusses the scope of the journal during a Meet the Editor session at the AACR Annual Meeting 2022.

Disseminating Discoveries

The AACR’s scientific journals program provides a renowned and respected publication venue for discoveries that span the breadth of basic, translational, clinical, and epidemiological cancer research.


In 2000, Douglas Hanahan, PhD, FAACR, and Robert A. Weinberg, PhD, FAACR, published their seminal review titled “The Hallmarks of Cancer.” In the paper, the authors proposed a set of six functional capabilities acquired by human cells as they move into neoplastic growth states, which are critical to the cells’ ability to form malignant tumors. This list of required capabilities for cancerous cells was expanded to a total of eight in a 2011 update. Since that time, the “Hallmarks of Cancer” model has been widely accepted by the cancer research community as the definitive conceptual framework for understanding human tumorigenesis.

In January, Dr. Hanahan chose Cancer Discovery as the publication forum for his long-awaited update to the Hallmarks framework. In a new review article titled “Hallmarks of Cancer: New Dimensions,” Dr. Hanahan evaluated his enduring conceptual model and recommended an expansion, proposing four new prospective hallmarks and enabling characteristics for consideration.

The impact of this re-evaluation of the foundations of cancer development was felt throughout the cancer research community; the paper had been cited nearly 600 times through December. The article’s Altmetric Attention Score of 1,631 ranked in the top five per cent of all articles tracked by Altmetric, and it was the top-ranked article ever published in Cancer Discovery.


At the time of its launch in October 2021, the open-access, online-only Cancer Research Communications was intended to enhance the AACR scientific journals portfolio by providing a venue for rapid open publication of hypotheses, methods, results, data resources, and new knowledge in all the varied disciplines of cancer science and medicine.

Under the leadership of founding editors-in-chief Elaine R. Mardis, PhD, FAACR, and Lillian L. Siu, MD, FRCPC, the journal quickly achieved that goal, publishing its 100th article around the time of its one-year anniversary. Drs. Mardis and Siu reflected on the early success of the journal in an Editorial in which they issued a call for submissions in several emerging areas of research, including cancer health disparities; big data and artificial intelligence; and the role of exercise, diet, and environmental stressors on cancer outcomes.

Cancer Research Communications editors-in-chief Elaine R. Mardis and Lillian L. journals portfolio


As part of its commitment to circulating innovative cancer science to a global audience, the AACR migrated its online journals portfolio to the cutting-edge Silverchair platform in February. The flexible, feature-rich platform features an advanced article display and easier access to the PDF versions of articles. Interest in the online journals continued to increase, as journal article views increased nearly 20 per cent during 2022.

Scientific Publishing by the Numbers


Total number of articles published in Cancer Research Communications in 2022.


Number of countries from which AACR journals received manuscript submissions in 2022.

35 days

Average turnaround time from submission to first decision across all AACR journals.


The AACR thanks its editors-in-chief for their hard work and stewardship of its scientific publishing program during 2022.

Blood Cancer Discovery

Blood Cancer Discovery cover
Riccardo Dalla-Favera

Riccardo Dalla-Favera, MD, FAACR

Columbia University
New York, New York

Kenneth C. Anderson

Kenneth C. Anderson, MD, FAACR

Dana-Farber Cancer Institute
Boston, Massachusetts

Cancer Discovery

Cancer Discovery Cover
Lewis C. Cantley

Lewis C. Cantley, PhD, FAACR

Dana-Farber Cancer Institute
Boston, Massachusetts

Luis A. Diaz

Luis A. Diaz, Jr., MD, FAACR

Memorial Sloan Kettering Cancer Center
New York, New York

Cancer Epidemiology, Biomarkers & Prevention

Cancer Epidemiology, Biomarkers & Prevention
Elizabeth A. Platz

Elizabeth A. Platz, ScD, MPH

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland

Cancer Immunology Research

Cancer Immunology Research
Robert D. Schreiber

Robert D. Schreiber, PhD, FAACR

Washington University School of Medicine
St. Louis, Missouri

Philip D. Greenberg

Philip D. Greenberg, MD, FAACR

Fred Hutchinson Cancer Research Center
Seattle, Washington

Cancer Prevention Research

Cancer Prevention Research
Raymond N. DuBois

Raymond N. DuBois, MD, PhD, FAACR

Medical University of South Carolina
Charleston, South Carolina

Michael N. Pollak

Michael N. Pollak, MD

McGill University
Montreal, Quebec, Canada

Cancer Research

Cancer Research cover
Chi Van Dang

Chi Van Dang, MD, PhD, FAACR

Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland

Cancer Research Communication

Cancer Research Communications cover
Elaine R. Mardis

Elaine R. Mardis, PhD, FAACR

Nationwide Children's Hospital
The Ohio State University
Columbus, Ohio

Lillian L. Siu

Lillian L. Siu, MD

Princess Margaret Cancer Centre
University of Toronto
Toronto, Ontario, Canada

Clinical Cancer Research

Clinical Cancer Research cover
Keith T. Flaherty

Keith T. Flaherty, MD

Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Molecular Cancer Research

Molecular Cancer Research cover
Massimo Loda

Massimo Loda, MD

Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College
New York, New York

Molecular Cancer Theraputics

Molecular Cancer Theraputics Cover
Beverly A. Teicher

Beverly A. Teicher, PhD

National Cancer Institute
Bethesda, Maryland

arrow to previous page AACR Annual Meeting 2022

AACR Annual Meeting 2022

AACR International

arrow to next page AACR International